Literature DB >> 9132599

Ataxia and slurred speech after artesunate treatment for falciparum malaria.

L G Miller, C B Panosian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9132599     DOI： 10.1056/NEJM199705013361818

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

Review 1.  Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

Authors:  B K Park; P M O'Neill; J L Maggs; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 2.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 3.  Artemisinin derivatives for treating uncomplicated malaria.

Authors:  H M McIntosh; P Olliaro
Journal:  Cochrane Database Syst Rev       Date:  2000

4.  Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate.

Authors:  W Ittarat; S Looareesuwan; P Pootrakul; P Sumpunsirikul; P Vattanavibool; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether.

Authors:  Laurens Manning; Moses Laman; Madhu Page-Sharp; Sam Salman; Ilomo Hwaiwhanje; Namar Morep; Peter Siba; Ivo Mueller; Harin A Karunajeewa; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

6.  Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.

Authors:  Pauline Byakika-Kibwika; Mohammed Lamorde; Harriet Mayanja-Kizza; Concepta Merry; Bob Colebunders; Jean-Pierre Van Geertruyden
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

7.  Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study.

Authors:  Peter Usman Bassi; Adeline I Osakwe; Ambrose Isah; Comfort Suku; Musa Kalat; Iliya Jalo; Robinson Daniel Wammanda; Chika Ugochukwu; Olubukula Adesina; Eno Etim Nyong; Frank Osungwu; Shanti Pal; Sylvester Chigozie Nwoasu; Magnus Wallberg; David Coulter
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

Review 8.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria.

Authors:  Timothy M E Davis; Tran Quang Binh; Kenneth F Ilett; Kevin T Batty; Hoang Lan Phuöng; Gregory M Chiswell; Vu Duong Bich Phuong; Cindy Agus
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 10.  Safety profile of Coartem: the evidence base.

Authors:  Catherine Falade; Christine Manyando
Journal:  Malar J       Date:  2009-10-12       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.